[1]
“Treatment of Psoriasiform Drug Eruptions in Patients on Immune Checkpoint Inhibitors”, Can Dermatol Today, vol. 7, no. 2, pp. 14–18, Jun. 2026, doi: 10.58931/cdt.2026.72162.